Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study
Yıl: 2022 Cilt: 52 Sayı: 1 Sayfa Aralığı: 105 - 112 Metin Dili: İngilizce DOI: 10.3906/sag-2109-84 İndeks Tarihi: 13-06-2022
Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study
Öz: Background/aim: Post-ERCP cholangitis (endoscopic retrograde cholangiopancreatography) and associated sepsis can be lifethreatening. Despite the wealth of studies on post-ERCP pancreatitis risk factors, there is limited data on post-ERCP cholangitis. This
study aimed to investigate the rates, predictors, and outcomes of post-ERCP cholangitis.
Materials and methods: A retrospective review of 452 ERCP cases performed by a single endoscopist at a tertiary center between
March 2019 and February 2021 was performed. Patient-related, organizational and periprocedural factors that could affect post-ERCP
cholangitis were evaluated. Predictors of post-ERCP cholangitis were determined by multivariable analysis.
Results: The post-ERCP cholangitis rate was 19.5%. Cholangiocarcinoma (OR 15.72, CI 2.43–101.55, p = 0.004), the American Society
of Anesthesiologist Score (ASA) (OR 2.87, CI 1.14–7.21, p = 0.024), an increase in bilirubin after ERCP (OR 1.81 CI 1.01–3.22, p =
0.043), body mass index (OR 1.15, CI 1.00–1.33, p = 0.04) and procedure duration (OR 1.02, CI 1.00–1.05, p = 0.049) were predictors of
post-ERCP cholangitis. Biliary stone extraction using a balloon was found to be protective against cholangitis (OR 0.18, CI 0.05–0.60, p
= 0.005). Sepsis rate related to post-ERCP cholangitis was 2.4% and death 1%.
Conclusion: Patients who undergo ERCP procedures due to malignant bile duct stenosis, have a high ASA score and BMI, and have a
long procedure time should be paid attention and closely monitored. Further research is needed to determine whether measures aimed
at the identified risk factors will reduce the incidence of post-ERCP.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Chak A, Cooper GS, Lloyd LE, Hammar PJ, Issa K et al. Effectiveness of ERCP in cholangitis: A community-based study. Gastrointestinal Endoscopy 2000;52:484–489. doi: 10.1067/mge.2000.108410
- 2. Adler DG, Baron TH, Davila RE, Egan J, Hirota WK et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointestinal Endoscopy 2005;62:1– 8. doi: 10.1016/j.gie.2005.04.015
- 3. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V et al. Complications of ERCP. Gastrointestinal Endoscopy 2012;75:467–473. doi: 10.1016/j.gie.2011.07.010
- 4. Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. American Journal of Gastroenterology 2007;102:1781–1788. doi: 10.1111/j.1572- 0241.2007.01279.x
- 5. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME et al. Complications of endoscopic biliary sphincterotomy. New England Journal of Medicine 1996;335:909–918. doi: 10.1056/ NEJM199609263351301
- 6. Ishigaki T, Sasaki T, Serikawa M, Kobayashi K, Kamigaki M et al. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis. Hepatogastroenterology 2015;62:417–424
- 7. Lee JM, Lee SH, Jang DK, Chung KH, Park JM et al. Air cholangiography in endoscopic bilateral stent-in-stent placement of metallic stents for malignant hilar biliary obstruction. Therapotic Advences in Gastroenterology 2015;9:189–198. doi: 10.1177/1756283X15618132
- 8. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of Endoscopic Retrograde Cholangiopancreatography (ERCP): A study of 10,000 cases. Gastroenterology 1976;70:314–320. doi: 10.1016/S0016-5085(76)80139-4
- 9. Desai R, Patel U, Doshi S, Zalavadia D, Siddiq W et al. A Nationwide Assessment of the “July Effect” and Predictors of Post-Endoscopic Retrograde Cholangiopancreatography Sepsis at Urban Teaching Hospitals in the United States. Clinical Endoscopy 2019;52:486–496. doi: 10.5946/ce.2018.190
- 10. Chen M, Wang L, Wang Y, Wei W, Yao Y-L et al. Risk factor analysis of post-ERCP cholangitis: A single-center experience. Hepatobiliary Pancreatic Disease International 2018;17:55–58. doi: 10.1016/j.hbpd.2018.01.002
- 11. Tierney J, Bhutiani N, Stamp B, Richey JS, Bahr MH et al. Predictive risk factors associated with cholangitis following ERCP. Surgical Endoscopy 2018;32:799–804. doi: 10.1007/ s00464-017-5746-z
- 12. Todani T, Narusue M, Watanabe Y, Tabuchi K, Okajima K. Management of congenital choledochal cyst with intrahepatic involvement. Annals of Surgery 1978;187:272. doi: 10.1097/00000658-197803000-00011
- 13. Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF et al. Risk factors for complication following ERCP; results of a largescale, prospective multicenter study. Endoscopy 2007;39:793– 801. doi: 10.1055/s-2007-966723
- 14. Pereira Lima JC, Arciniegas Sanmartin ID, Latrônico Palma B, Oliveira dos Santos CE. Risk Factors for Success, Complications, and Death after Endoscopic Sphincterotomy for Bile Duct Stones: A 17-Year Experience with 2,137 Cases. Digestive Disease 2020;38:534–541. doi: 10.1159/000507321
- 15. Kim NH, Kim HJ, Bang KB. Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis. Hepatobiliary Pancreatic Disease Internaional 2017;16:512–518. doi: 10.1016/S1499-3872(17)60056-0
- 16. Lübbert C, Wendt K, Feisthammel J, Moter A, Lippmann N et al. Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents: a prospective cohort study. PLoS One 2016;11:e0155479. doi: 10.1371/journal. pone.0155479
- 17. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointestinal Endoscopy 2009;70:80– 88. doi: 10.1016/j.gie.2008.10.039
- 18. Kwak N, Yeoun D, Arroyo-Mercado F, Mubarak G, Cheung D et al. Outcomes and risk factors for ERCP-related complications in a predominantly black urban population. BMJ Open Gastroenterology 2020;7. doi: 10.1136/bmjgast-2020-000462
- 19. Biondo S, Kreisler E, Fraccalvieri D, Basany EE, Codina‐Cazador A et al. Risk factors for surgical site infection after elective resection for rectal cancer. A multivariate analysis on 2131 patients. Colorectal Disease 2012;14:e95–102. doi: 10.1111/j.1463-1318.2011.02798.x
- 20. Nagaya LH, Salles MJC, Takikawa LSC, Fregoneze M, Doneux P et al. Infections after shoulder arthroplasty are correlated with higher anesthetic risk score: a case-control study in Brazil. Brazilian Journal of Infectius Disease 2017;21:613–619. doi: 10.1016/j. bjid.2017.06.003
- 21. Lenguerrand E, Whitehouse MR, Beswick AD, Kunutsor SK, Foguet P et al. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect ious Disease 2019;19:589–600. doi: 10.1016/S1473-3099(18)30755-2
- 22. Doganay M, Yuksek YN, Daglar G, Gozalan U, Tutuncu T et al. Clinical determinants of suppurative cholangitis in malignant biliary tract obstruction. Bratisl Lek Listy 2010;111:336–339
- 23. Khashab MA, Kim K, Hutfless S, Lennon AM, Kalloo AN et al. Predictors of early stent occlusion among plastic biliary stents. Digestive Disease Science 2012;57:2446–2450. doi: 10.1007/ s10620-012-2178-4
- 24. Ertuğrul I, Yüksel I, Parlak E, Ciçek B, Ataseven H et al. Risk factors for endoscopic retrograde cholangiopancreatographyrelated cholangitis: a prospective study. Turkish Journal of Gastroenterology 2009;20:116–121
- 25. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proceedings of Nutrition Society 2012;71:298–306. doi: 10.1017/S0029665112000158
- 26. Khashab MA, Chithadi K V, Acosta RD, Bruining DH, Chandrasekhara V et al. Antibiotic prophylaxis for GI endoscopy. Gastrointestinal Endoscopy 2015;81:81–89. doi: 10.1016/j. gie.2014.08.008
- 27. Wang S, Gao D, Shi Z, Rui LU, Wang S et al. A prospective randomized study on digestive tract cleaning before ERCP for the prevention of postprocedure cholangitis. Chinese Journal of Digestive Endoscopy 2011;28:555–558. doi:10.3760/cma.j.is sn.1007-5232.2011.10.005
- 28. Norouzi A, Khatibian M, Afroogh R, Chaharmahali M, Sotoudehmanesh R. The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for noncalculous biliary obstruction, a randomized controlled trial. Indian Journal of Gastroenterology 2013;32:18–21. doi: 10.1007/s12664- 012-0208-y
- 29. Calderwood AH, Day LW, Muthusamy VR, Collins J, Hambrick RD et al. ASGE guideline for infection control during GI endoscopy. Gastrointestinal Endoscopy 2018;87:1167–1179. doi: org/10.1016/j.gie.2017.12.009
| APA | YILMAZ H, Koçyiğit B (2022). Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. , 105 - 112. 10.3906/sag-2109-84 |
| Chicago | YILMAZ HASAN,Koçyiğit Burcu Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. (2022): 105 - 112. 10.3906/sag-2109-84 |
| MLA | YILMAZ HASAN,Koçyiğit Burcu Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. , 2022, ss.105 - 112. 10.3906/sag-2109-84 |
| AMA | YILMAZ H,Koçyiğit B Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. . 2022; 105 - 112. 10.3906/sag-2109-84 |
| Vancouver | YILMAZ H,Koçyiğit B Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. . 2022; 105 - 112. 10.3906/sag-2109-84 |
| IEEE | YILMAZ H,Koçyiğit B "Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study." , ss.105 - 112, 2022. 10.3906/sag-2109-84 |
| ISNAD | YILMAZ, HASAN - Koçyiğit, Burcu. "Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study". (2022), 105-112. https://doi.org/10.3906/sag-2109-84 |
| APA | YILMAZ H, Koçyiğit B (2022). Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. Turkish Journal of Medical Sciences, 52(1), 105 - 112. 10.3906/sag-2109-84 |
| Chicago | YILMAZ HASAN,Koçyiğit Burcu Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. Turkish Journal of Medical Sciences 52, no.1 (2022): 105 - 112. 10.3906/sag-2109-84 |
| MLA | YILMAZ HASAN,Koçyiğit Burcu Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. Turkish Journal of Medical Sciences, vol.52, no.1, 2022, ss.105 - 112. 10.3906/sag-2109-84 |
| AMA | YILMAZ H,Koçyiğit B Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. Turkish Journal of Medical Sciences. 2022; 52(1): 105 - 112. 10.3906/sag-2109-84 |
| Vancouver | YILMAZ H,Koçyiğit B Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study. Turkish Journal of Medical Sciences. 2022; 52(1): 105 - 112. 10.3906/sag-2109-84 |
| IEEE | YILMAZ H,Koçyiğit B "Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study." Turkish Journal of Medical Sciences, 52, ss.105 - 112, 2022. 10.3906/sag-2109-84 |
| ISNAD | YILMAZ, HASAN - Koçyiğit, Burcu. "Predictors of postendoscopic retrograde cholangiopancreatography associated cholangitis: a retrospective cohort study". Turkish Journal of Medical Sciences 52/1 (2022), 105-112. https://doi.org/10.3906/sag-2109-84 |
